High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy

Malar J. 2014 Aug 12:13:312. doi: 10.1186/1475-2875-13-312.

Abstract

Background: The immunosuppressive properties of HLA-G protein can create a tolerogenic environment that may allow Plasmodium falciparum to avoid host immune responses. There are known associations between high levels of circulating soluble HLA-G (sHLA-G) and either parasite or viral infections and it has been suggested that the induction of sHLA-G expression could be a mechanism via which infectious agents subvert host immune defence. The study presented here is the first to investigate the possible association between sHLA-G and malaria or malaria related risk factors in Benin.

Methods: A parasitological and clinical follow-up of 165 mothers and their newborns from delivery through to one year of age was conducted in the Tori Bossito area of southern Benin. Plasma levels of sHLA-G were determined by ELISA in maternal peripheral and cord blood and again in infants' peripheral blood at 3, 6, 9 and 12 months of age. The associations between the levels of sHLA-G and malaria risk factors were investigated through multivariate mixed models.

Results: Strong correlations were observed between the maternal and cord plasma concentrations of sHLA-G. In multivariate analyses, high cord plasma levels of sHLA-G were independently associated with (i) low birth weight and (ii) an increased risk of P. falciparum infection in infancy.

Conclusion: These results show for the first time the possible involvement of sHLA-G in generating immune tolerance during pregnancy-associated malaria. Soluble HLA-G may represent a useful marker of susceptibility to malaria in infants and be associated with the higher susceptibility to infection observed for LBW children.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Benin / epidemiology
  • Cohort Studies
  • Disease Susceptibility*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HLA-G Antigens / blood*
  • Humans
  • Infant
  • Infant, Low Birth Weight*
  • Infant, Newborn
  • Malaria, Falciparum / epidemiology*
  • Male
  • Middle Aged
  • Pregnancy
  • Risk Assessment
  • Young Adult

Substances

  • HLA-G Antigens